Abstract:Diphthamide is a unique post-translationally modified histidine residue (His715 in all mammals) found only in eukaryotic elongation factor-2 (eEF-2). The biosynthesis of diphthamide represents one of the most complex modifications, executed by protein factors conserved from yeast to humans. Diphthamide is not only essential for normal physiology (such as ensuring fidelity of mRNA translation), but is also exploited by bacterial ADP-ribosylating toxins (e.g., diphtheria toxin) as their molecular target in pathogenesis. Taking advantage of the observation that cells defective in diphthamide biosynthesis are resistant to ADP-ribosylating toxins, in the past four decades, seven essential genes (Dph1 to Dph7) have been identified for diphthamide biosynthesis. These technically unsaturated screens raise the question as to whether additional genes are required for diphthamide biosynthesis. In this study, we performed two independent, saturating, genome-wide CRISPR knockout screens in human cells. These screens identified all previously known Dph genes, as well as further identifying the BTB/POZ domain-containing transcription factor Miz1. We found that Miz1 is absolutely required for diphthamide biosynthesis via its role in the transcriptional regulation of Dph1 expression. Mechanistically, Miz1 binds to the Dph1 proximal promoter via an evolutionarily conserved consensus binding site to activate Dph1 transcription. Therefore, this work demonstrates that Dph1-7, along with the newly identified Miz1 transcription factor, are likely to represent the essential protein factors required for diphthamide modification on eEF2.Diphthamide is a unique post-translationally modified histidine residue (His699 in yeast, His715 in all mammals) found only in eukaryotic elongation factor-2 (eEF-2). Mice that are deficient in diphthamide biosynthesis are embryonic lethal, attesting to the importance of diphthamide in normal physiology. It has taken four decades to identify the seven non-redundant genes in diphthamide biosynthesis, but whether additional factors are required and how the pathway is regulated remained elusive. To address these issues, we performed two saturating, independent, and unbiased genome-wide CRISPR knockout screens. The screens concluded independently that Dph1-Dph7 and additionally transcription factor Miz1 are the key factors required for diphthamide biosynthesis. Mechanistically, Miz1 binds to the Dph1 proximal promoter via an evolutionarily conserved consensus binding site to activate Dph1 transcription. While diphthamide biosynthesis machinery (Dph1-Dph7) exists across eukaryotes, Miz1 orthologues do not exist in lower species such as yeast, C. elegans, and Drosophila, indicating that the regulation of diphthamide modification by Miz1 emerged much later in evolution. The work opens a new avenue for understanding the role that diphthamide modification plays in normal physiology and bacterial toxin pathogenesis.

Diphthamide promotes TOR signaling by increasing the translation of proteins in the TORC1 pathway

O-GlcNAcylation of Core Components of the Translation Initiation Machinery Regulates Protein Synthesis.

Dopamine D2 Receptor Modulates Wnt Expression and Control of Cell Proliferation

Autophagy Regulates Rrna Synthesis

Dph7 Catalyzes a Previously Unknown Demethylation Step in Diphthamide Biosynthesis.

Identification of the transcription factor Miz1 as an essential regulator of diphthamide biosynthesis using a CRISPR-mediated genome-wide screen

Diphthamide formation in Arabidopsis requires DPH1-interacting DPH2 for light and oxidative stress resistance

Regulation of cellular growth by the Drosophila target of rapamycin dTOR

DTF1 is a Core Component of RNA-directed DNA Methylation and May Assist in the Recruitment of Pol IV

Diphthamide deficiency promotes association of eEF2 with p53 to induce p21 expression and neural crest defects

Regulatory Function of Phosphorylation and Ubiquitination on The TORC1 Signaling Pathway

TOR-dependent post-transcriptional regulation of autophagy

Ythdf2-mediated STK11 mRNA decay supports myogenesis by inhibiting the AMPK/mTOR pathway

Coordinated regulation of protein synthesis and degradation by mTORC1

DAPK enhances DDX20 protein stability via suppression of TRIM25-mediated ubiquitination-based DDX20 degradation

DOA/CLK2 phosphorylates Fl(2)d/WTAP to enhance m6A mRNA methyltransferase complex activity

Chemogenomic Approach Identified Yeast Ylr143w As Diphthamide Synthetase

TOR signaling inhibition in intestinal stem and progenitor cells affects physiology and metabolism in Drosophila

An mTORC1-Mdm2-Drosha axis for miRNA biogenesis in response to glucose- and amino acid-deprivation.

A snoRNA-tRNA modification network governs codon-biased cellular states

O-GlcNAcylation determines the translational regulation and phase separation of YTHDF proteins